CAR-T cell therapy can be a last hope for some pediatric patients and their families. Patrick Brown, director of the Pediatric Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins explains the excitement about this new therapy, which patients are the best candidates and why Johns Hopkins Children’s Center is one of the few East Coast hospitals approved to provide this treatment.
Related Presenters
Dr. Brown's research is focused on developing new therapies for childhood leukemia. Leukemia (cancer of the blood-forming cells in the bone marrow) is the most common form of cancer in children. While great improvements have been made ...
